Computed tomography in ambulatory settings
Ask the expert
The report presents a summary of reimbursement situation for computed tomography (CT) in ambulatory settings.
Both computed tomography with and without contrast is considered.
All procedure codes will be provided in the analysis.
When fee for service payment model is used, all fees for available reimbursement codes will be provided.
When DRG payment model is used, reimbursement analysis will cover the following indications:
- CT of head in cerebral infarction
- CT of chest in interstitial lung disease
- CT of abdomen in nephrolithiasis
The only reimbursement within public / statutory health insurance systems is considered.
Policy analysis will include reimbursement decisions and health technology assessments for stand-alone CT imaging method. Recommendations for CT imaging as part of broader evaluations or clinical guidelines is not be considered.
Report includes essential information about reimbursement and national funding, including:
- Brief overview of reimbursement system for medical devices
- Procedure coding for technology
- Diagnosis coding
- Payment mechanism for technology
- Reimbursement tariffs for technology
- Restrictions in indications or scenarios for use of technology
- Policy considerations by payers and policy-makers about technology
Reimbursement information is provided for the following geographies:
- England (UK)
It is also possible to add analysis in Czech Republic, Finland, Hungary, Romania, Russia and Turkey.
Manufacturers of equipment for computed tomography (CT) in ambulatory settings include:
- Anke tech (Anatom)
- Asahiroentgen (Alphard)
- Canon Medical System Europe
- Carestream (OnSight 3D Extremity System)
- CT Imaging (BREAST-CT)
- CurveBeam (Inreach)
- DIGIRAD (DIGIRAD CARDIUS XACT)
- FUJIFILM (FCT SPEEDIA HD)
- Gamma Star
- GE Healthcare (REVOLUTION FRONTIER)
- Genoray (Volux)
- I-Cat (I-CAT Precise)
- iCRco (Clariscbct)
- Koning Corporation
- Mediso (ANYSCAN)
- MinFound Medical Systems
- Neurologica (BODYTOM)
- Philips Healthcare (Gemini)
- Planmed (Verity)
- PointNix (POINT I 3D)
- SinoVision (INSITUM)
- Scanco Medical (XTREMECT)
- Vatech (Pax-Flex3D)
- Xoran (Minicat)
Table of content is not available at the moment. Report is still ongoing.
In August 2019, the Decision Forum conducted the meeting towards the funding decisions for new methods, where concluded that prehospital CT ("stroke ambulance") for early diagnosis and treatment of suspected stroke can be used within the framework of controlled studies with a sufficient number of patients. The protocol of the Decision Forum meeting was released on the website of the New Method.Read more
In June 2019, the Norwegian Institute of Public Health (NIPH) has released an HTA report for prehospital CT for early diagnosis and treatment of suspected acute stroke or severe head injury to evaluate the documentation for clinical efficacy, safety and possible initiation of treatment prior to arrival in hospitals, compared with current hospital practice. Although the mobile stroke unit care increases the number of patients who receive thrombolysis, its efficacy is unknown due to the lack of evidence.Read more
On February 19, 2019, the Nomenclature was updated. The update brought changes in chapter V and VI of Nomenclature, regarding the creation of new codes for laser destruction of congenital port-wine stains, hearing aids and cone beam computed tomography.Read more
The report presents a summary of reimbursement situation for computed tomography (CT) in ambulatory settings. Both computed tomography with and without contrast is considered. All procedure codes will be provided in the analysis. When fee for service payment model is used, all fees for available reimbursement codes will be provided. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.Read more